UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| ||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | SEC 1473 (7-02) | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1. Title of Derivative Security (Instr. 4) |
2. Date Exercisable and Expiration Date (Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) |
4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) |
6. Nature of Indirect Beneficial Ownership (Instr. 5) |
||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
ABBOTT LABORATORIES Â |
 |  X |  |  |
CFR International SpA 100 ABBOTT PARK ROAD AP6A-2, D-032L ABBOTT PARK, IL 60064-6092 |
 |  X |  |  |
Brian B. Yoor, By John A. Berry, Attorney-in-Fact. | 12/30/2016 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
 Remarks: A total of 21,818,118 shares of Common Stock of AquaBounty Technologies, Inc. ("AquaBounty") described in this report are held directly by CFR International SpA ("CFR International"). CFR International is an indirect, wholly-owned subsidiary of Abbott Laboratories ("Abbott"). In Abbott's capacity as the ultimate corporate parent of CFR International, Abbott may be deemed to indirectly beneficially own such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Securities and Exchange Commission thereunder. Western Pharmaceuticals SA, an indirect, wholly-owned subsidiary of Abbott ("Western Pharmaceuticals"), holds an additional 311,922 shares of Common Stock of AquaBounty.  Western Pharmaceuticals is subject to liquidation proceedings and voting and dispositive control over such shares is exercised by a liquidator appointed pursuant to Ecuadoran law.  For purposes of this report, such shares have been included in the shares of Common Stock reported as indirectly owned by Abbott. Exhibit List - Exhibit 24.1 - Powers of Attorney. |